Excited to share that I’ll be joining the Center for Addiction Sciences and Therapeutics (CAST) and the Department of Psychiatry & Behavioral Sciences at the University of Texas Medical Branch as an Assistant Professor of Research.
This Hot Topic article suggests that combining pharmacological and behavioral approaches to target dysfunctional prefrontal circuits is a promising approach to reduce relapse in addiction
nature.com/articles/s41386-0…
Researchers are optimistic about psychedelic drugs as potential treatments for depression and mood disorders, despite pushback having stalled the field
go.nature.com/4e1WDEM
DEADLINE EXTENSION.
Symposia proposals are now due by NOVEMBER 16th 2026.
We are seeking proposals that explore behavioural pharmacology, psychology, psychiatry, pharmacology, and neuroscience.
More information and a link to submit on our website ebps.org/events/ebps-2027-bi…
Why do some cannabis users never develop addiction while 1/10 progress to cannabis use disorder? A new genetic study reveals that cannabis use vs use disorder are wired differently: distinct brain networks, genes, and biology
nature.com/articles/s41386-0…
5-HT1B receptors expressed on forebrain excitatory neurons mediate the post-acute anxiolytic response to psilocybin in mice
doi.org/10.1007/s00213-026-0…
"Connectedness showed the strongest statistical association with improvements in wellbeing and accounted for the largest proportion of variance in wellbeing change, followed by reductions in the anxiety facet of neuroticism and absorption."
frontiersin.org/journals/psy…
Serotonin biology as a basis for explaining psychedelic drug action - we learned a lot writing this review for @CurrentBiologycell.com/current-biology/ful…
We know a good deal about serotonin, which should teach us how psychedelics work. But what’s the same? What’s different? 🤔
1/4
It's October, so its horror movie season👻🎃
To assist with deciding what to watch, I created Halloween horror movie bingo to help ensure diversity in choices across horror sub-genres.
Thru October, I will be updating with recs for each category. Lets see who gets all 31!
The first 2 sentences of this paper are brutal.
"Unintentional drug overdose is the leading cause of maternal death in the US. Opioid use disorder (OUD) during pregnancy has increased more than 7-fold over the past 2 decades."
the good news is they find that buprenorphine and naltrexone can decrease overdose/death up to a year after birth, as long as the medications are being prescribed, and the longest the better. Unfortunatly there are still large stigma and hurdles to get these medications, and only 1/4 gets them. so much more should be done to increase access.
jamanetwork.com/journals/jam…
**Recruitment**
We are looking to hire a psychiatrist/scientist (MD or MD/PhD) who focuses on neuromodulation, particularly rTMS in the Department of Psychiatry at the University of Calgary. Come join myself, @MayoOnTheBrain and more.
Details 👇
careers.ucalgary.ca/jobs/182…
Excited to head back to Ireland for the #EBPS2027 meeting. The keynotes are 🔥 and we are looking to round off the program with symposium proposals, open until October 31st.
Symposia Submissions for #EBPS2027 in Cork, Ireland are now open. We have a great lineup of keynote presentations and are seeking symposia proposals covering a range of behavioural pharmacology topics.
More information on our website
ebps.org/events/ebps-2027-bi…
📢 Call for papers: Cannabis & Cannabinoid Research special issue on minor cannabinoids (CBG, CBN, THCV, CBDV, acidic + semisynthetic).
Mechanisms, PK, chemistry, safety, policy.
Deadline April 30, 2027. Select the special issue in ScholarOne. 🧪
journals.sagepub.com/page/cc…
We are seeking papers for two special issues that the EBPS is guest editing in our partner journal @PsychopharmEBPS. We are seeking papers for both special issues.
ALT Confused Stephen Colbert GIF by The Late Show With Stephen Colbert
New in @NEJM: rescheduling medical cannabis to Schedule III would clear some research barriers. We discuss what’s missing, and what it means for the science and public health nejm.org/doi/abs/10.1056/NEJ…
Perspective by Rebecca L. Haffajee, JD, PhD, MPH, Robert A. Mikos, JD, and Ziva D. Cooper, PhD: Marijuana Rescheduling — A Game Changer for Research? nej.md/3UHkp1H#HealthPolicy#HealthLaw
ALT A quote from a Perspective published in the New England Journal of Medicine reads as follows: "Rescheduling can accomplish its primary purpose of generating clinically meaningful data only if Congress and the executive branch allocate more funding for doing that work." The Perspective is titled "Marijuana Rescheduling — A Game Changer for Research?" and the authors are Rebecca L. Haffajee, J.D., Ph.D., M.P.H., Robert A. Mikos, J.D., and Ziva D. Cooper, Ph.D. The text is displayed on a simple white background with a brown border. The NEJM identity sits at the bottom.